Skip to content

The relationship between mindfulness, pain intensity, pain catastrophizing, depression, and quality of life among cancer survivors living with chronic neuropathic pain.

Patricia A Poulin, Heather Romanow, Noriyeh Rahbari, Rebecca Small, Catherine E Smyth, Taylor Hatchard, Brahm K Solomon, Xinni Song, Cheryl A Harris, John Kowal, Howard J Nathan, Keith G Wilson

Supportive Care in Cancer October 2016 DOI: 10.1007/s00520-016-3243-x (opens in new tab)

Study at a glance

AI-extracted from the abstract
Characteristics Cross-sectional survey Peer reviewed
Sample size 76
Population Cancer survivors with chronic neuropathic pain, at least 1 year post-treatment, no evidence of cancer, neuropathic pain symptoms for more than three months; 24% men and 76% women, average age 56.5 years (SD = 9.4)
Measures Five Facets Mindfulness Questionnaire (FFMQ), pain intensity, pain catastrophizing, pain interference, depression, health-related quality of life (HRQOL)
Topics Depression Meditation
Keywords Cancer Chronic neuropathic pain Disability Quality of life
Key findings Mindfulness was negatively correlated with pain intensity, pain catastrophizing, pain interference, and depression, and positively correlated with mental health-related quality of life. Regression analyses showed mindfulness predicted lower pain intensity and depression and better mental health-related quality of life after controlling for pain catastrophizing, age, and gender. The authors argue mindfulness may mitigate the impact of pain in cancer survivors with chronic neuropathic pain.

Abstract

This study aims to examine if mindfulness is associated with pain catastrophizing, depression, disability, and health-related quality of life (HRQOL) in cancer survivors with chronic neuropathic pain (CNP). We conducted a cross-sectional survey with cancer survivors experiencing CNP. Participants (n = 76) were men (24 %) and women (76 %) with an average age of 56.5 years (SD = 9.4). Participants were at least 1 year post-treatment, with no evidence of cancer, and with symptoms of neuropathic pain for more than three months. Participants completed the Five Facets Mindfulness Questionnaire (FFMQ), along with measures of pain intensity, pain catastrophizing, pain interference, depression, and HRQOL. Mindfulness was negatively correlated with pain intensity, pain catastrophizing, pain interference, and depression, and it was positively correlated with mental health-related HRQOL. Regression analyses demonstrated that mindfulness was a negative predictor of pain intensity and depression and a positive predictor of mental HRQOL after controlling for pain catastrophizing, age, and gender. The two mindfulness facets that were most consistently associated with better outcomes were non-judging and acting with awareness. Mindfulness significantly moderated the relationships between pain intensity and pain catastrophizing and between pain intensity and pain interference. It appears that mindfulness mitigates the impact of pain experiences in cancer survivors experiencing CNP post-treatment. This study suggests that mindfulness is associated with better adjustment to CNP. This provides the foundation to explore whether mindfulness-based interventions improve quality of life among cancer survivors living with CNP.

Comparable studies

Other cross-sectional and survey studies on depression, most cited first.

Study Year Design Participants
Psychological flexibility mediates the relations between acute psychedelic effects and subjective decreases in depression and anxiety. International sample of people who reported having used a psychedelic 2020 Cross-sectional survey n = 985
5-methoxy-N,N-dimethyltryptamine (5-MeO-DMT) used in a naturalistic group setting is associated with unintended improvements in depression and anxiety. Adults who used 5-MeO-DMT in a group setting with structured procedures 2019 Cross-sectional survey n = 362
Psychological and neuropsychological assessment of regular hoasca users. Regular hoasca users from a U.S. branch of União do Vegetal and matched non-user controls 2016 Cross-sectional study n = 57
Adults who microdose psychedelics report health related motivations and lower levels of anxiety and depression compared to non-microdosers Self-selected microdosers and non-microdosers recruited via a mobile application 2021 Cross-sectional survey n = 8,703
Effects of Naturalistic Psychedelic Use on Depression, Anxiety, and Well-Being: Associations With Patterns of Use, Reported Harms, and Transformative Mental States. Adults with at least one lifetime psychedelic experience 2022 Cross-sectional survey n = 2,510

Citations in the library

Cited by 14

and 9 more in the library

Cites 9

and 4 more in the library

Explore topics